Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?

Basit Öğe Kaydı
dc.authorid0000-0002-5078-3176
dc.authorid0000-0003-4634-205X
dc.authorid0000-0001-8127-9995
dc.authorid0000-0001-8165-234X
dc.authorid0000-0003-3599-2719
dc.authorid0000-0002-9449-9302
dc.authorid0000-0002-5397-8841
dc.contributor.authorMentes, Oral
dc.contributor.authorCelik, Deniz
dc.contributor.authorYildiz, Murat
dc.contributor.authorOzdemir, Tarkan
dc.contributor.authorAri, Maside
dc.contributor.authorAksoy Guney, Eda Nur
dc.contributor.authorAri, Emrah
dc.date.accessioned2026-01-24T12:29:30Z
dc.date.available2026-01-24T12:29:30Z
dc.date.issued2025
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractBackground: Atrial fibrillation (AF) frequently occurs in individuals with hypercapnic type 2 respiratory failure and has the potential to adversely affect patient outcomes. This study sought to investigate the clinical features and prognostic significance of atrial fibrillation in patients admitted to the intensive care unit with hypercapnic type 2 respiratory failure. Methods: This retrospective, single-center study included 200 adult patients diagnosed with hypercapnic type 2 respiratory failure between May 2022 and May 2023. Patients were grouped according to whether atrial fibrillation was present or not. Demographic, laboratory, and echocardiographic findings, comorbidities, and outcomes were compared. Kaplan-Meier survival analysis and Cox regression were used to identify mortality predictors. Results: AF was present in 50.5% of patients. Those with AF were older, had higher Charlson Comorbidity Index scores, and a greater prevalence of heart failure (p < 0.001). No significant differences were found in arterial blood gas values. AF patients had higher urea, creatinine, and BNP levels, and lower hemoglobin, lymphocyte, eosinophil, and monocyte counts (p < 0.05). Echocardiography showed more severe tricuspid and mitral regurgitation, lower ejection fractions, and higher systolic pulmonary pressures in the AF group. About 20% of AF patients were not receiving anticoagulants at ICU admission. AF was associated with shorter survival (49.6 +/- 4.07 vs. 61.4 +/- 3.8 days, p = 0.031) and 1.6-fold higher mortality risk (HR: 1.60, 95% CI: 1.04-2.47). Advanced age and low hemoglobin were independent predictors of mortality. Conclusions: AF is frequent among patients with type 2 respiratory failure and is linked to increased mortality. Despite known complications, treatment remains underutilized. AF should be actively screened during ICU admissions for respiratory failure.
dc.identifier.doi10.3390/diagnostics15131612
dc.identifier.issn2075-4418
dc.identifier.issue13
dc.identifier.pmid40647611
dc.identifier.scopus2-s2.0-105010273455
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.3390/diagnostics15131612
dc.identifier.urihttps://hdl.handle.net/20.500.12868/5412
dc.identifier.volume15
dc.identifier.wosWOS:001527241000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofDiagnostics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260121
dc.subjecthypercapnic respiratory failure
dc.subjectatrial fibrillation
dc.subjectmortality
dc.subjectCOPD
dc.subjectsurvival analysis
dc.titleAtrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu